CD25 expression and outcomes in older patients with acute myelogenous leukemia treated with plerixafor and decitabine

We investigated CD25 expression in older (≥60 years) patients with new acute myelogenous leukemia treated with decitabine and plerixafor. Patients resistant to therapy or survival ≤1 year had significantly higher percentages of CD25(pos) myeloid blasts in baseline bone marrow. CD25(pos) patients had...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Leuk Lymphoma
Prif Awduron: Allan, John N., Roboz, Gail J., Askin, Gulce, Ritchie, Ellen, Scandura, Joseph, Christos, Paul, Hassane, Duane C., Guzman, Monica L.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2017
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5773411/
https://ncbi.nlm.nih.gov/pubmed/28718760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2017.1352089
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg